215 related articles for article (PubMed ID: 29502640)
1. Simple and Elaborated Clinician Reminder Prompts for Human Papillomavirus Vaccination: A Randomized Clinical Trial.
Zimet G; Dixon BE; Xiao S; Tu W; Kulkarni A; Dugan T; Sheley M; Downs SM
Acad Pediatr; 2018 Mar; 18(2S):S66-S71. PubMed ID: 29502640
[TBL] [Abstract][Full Text] [Related]
2. Effect of provider prompts on adolescent immunization rates: a randomized trial.
Szilagyi PG; Serwint JR; Humiston SG; Rand CM; Schaffer S; Vincelli P; Dhepyasuwan N; Blumkin A; Albertin C; Curtis CR
Acad Pediatr; 2015; 15(2):149-57. PubMed ID: 25748976
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state.
Christensen T; Zorn S; Bay K; Treend K; Averette C; Rhodes N
Hum Vaccin Immunother; 2023 Dec; 19(3):2274723. PubMed ID: 37929936
[TBL] [Abstract][Full Text] [Related]
4. Adolescent Vaccination Performance in South Carolina Compared to the United States.
Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702
[TBL] [Abstract][Full Text] [Related]
5. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
[TBL] [Abstract][Full Text] [Related]
6. EDITORIAL.
John JF
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):114. PubMed ID: 27141700
[No Abstract] [Full Text] [Related]
7. Missed opportunities for adolescent vaccination, 2006-2011.
Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
[TBL] [Abstract][Full Text] [Related]
8. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M
Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
[TBL] [Abstract][Full Text] [Related]
10. Collaborative patient-provider communication and uptake of adolescent vaccines.
Moss JL; Reiter PL; Rimer BK; Brewer NT
Soc Sci Med; 2016 Jun; 159():100-7. PubMed ID: 27176467
[TBL] [Abstract][Full Text] [Related]
11. Missed Opportunities for Human Papillomavirus Vaccine Initiation in an Insured Adolescent Female Population.
Espinosa CM; Marshall GS; Woods CR; Ma Q; Ems D; Nsiah I; Happe LE; Smith MJ
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):360-365. PubMed ID: 29036336
[TBL] [Abstract][Full Text] [Related]
12. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
14. Early Outcomes of a Multilevel Human Papillomavirus Vaccination Pilot Intervention in Federally Qualified Health Centers.
Fisher-Borne M; Preiss AJ; Black M; Roberts K; Saslow D
Acad Pediatr; 2018 Mar; 18(2S):S79-S84. PubMed ID: 29502642
[TBL] [Abstract][Full Text] [Related]
15. The preteen visit: an opportunity for prevention.
Campos-Outcalt D
J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
[TBL] [Abstract][Full Text] [Related]
17. Middle school vaccination requirements and adolescent vaccination coverage.
Bugenske E; Stokley S; Kennedy A; Dorell C
Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425
[TBL] [Abstract][Full Text] [Related]
18. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial.
Wilkinson TA; Dixon BE; Xiao S; Tu W; Lindsay B; Sheley M; Dugan T; Church A; Downs SM; Zimet G
Vaccine; 2019 Jul; 37(31):4414-4418. PubMed ID: 31201057
[TBL] [Abstract][Full Text] [Related]
19. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
20. Update on Adolescent Immunizations.
Schreier R; Halady T; Bishop N; Chatterjee A
S D Med; 2016 Feb; 69(2):78-83. PubMed ID: 26999915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
